Sec Form 13G Filing - KHANDROS IGOR Y @ Bruker Cellular Analysis Inc.

Sec Form 13G Filing - KHANDROS IGOR Y filing for Bruker Cellular Analysis Inc. (CELL) - 2021-02-16

Insider filing report for Changes in Beneficial Ownership

Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

(Rule 13d-102)

Under the Securities Exchange Act of 1934

(Amendment No. )¹

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT

TO RULE 13d-2

BERKELEY LIGHTS, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

084310101

(CUSIP Number)

July 16, 2020

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

¹	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 084310101		13G		Page 2 of 9


CUSIP No. 084310101		13G		Page 3 of 9


CUSIP No. 084310101		13G		Page 4 of 9


CUSIP No. 084310101		13G		Page 5 of 9

Item 1(a).

The name of the issuer is Berkeley Lights, Inc.

Item 1(b).

The address of the principal executive offices of the issuer is 5858 Horton Street, Suite 320, Emeryville, California 94608.

Item 2(a).

Name of Person Filing:

This statement on Schedule 13G is being filed pursuant to Rule 13d-1(d) under the Securities Exchange Act of 1934, as amended, by Igor Y. Khandros, the Khandros-Bloch Revocable Trust U/A/D January 24, 1997 and Susan Bloch (the “Reporting Persons”).

Item 2(b).

Address of Principal Business Office or, if none, Residence:

The address of each of the Reporting Persons is c/o Nutcracker Therapeutics, Inc., 5858 Horton Street, Emeryville, California 94608.

Item 2(c).

Citizenship:

Igor Y. Khandros and Susan Bloch are each citizens of the United States. The Khandros-Bloch Revocable Trust U/A/D January 24, 1997 was formed under the laws of the State of California.

Item 2(d).

Title of Class of Securities:

Common Stock, par value $0.00005 per share

Item 2(e).

CUSIP Number:

084310101

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:


(a)	☐	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)	☐	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)	☐	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)	☐	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

(e)	☐	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);


CUSIP No. 084310101		13G		Page 6 of 9



(f)	☐	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)	☐	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)	☐	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)	☐	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)	☐	Group, in accordance with §240.13d-1(b)(1)(ii)(J).

Item 4.

Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)

Amount beneficially owned: 9,284,898 shares of Common Stock.

(b)

Percent of class: 14.4% based on 64,368,569 shares of Common Stock outstanding as of October 31, 2020, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020.

(c)

Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote 0.

(ii)

Shared power to vote or to direct the vote 9,284,898.

(iii)

Sole power to dispose or to direct the disposition of 0.

(iv)

Shared power to dispose or to direct the disposition of 9,284,898.

The Khandros-Bloch Revocable Trust U/A/D January 24, 1997 owns 9,083,384 shares of the Issuer’s outstanding common stock; the Khandros 2018 3-Year GRAT owns 100,757 shares of the Issuer’s outstanding common stock; and the Bloch 2018 3-Year GRAT owns 100,757 shares of the Issuer’s common stock. Igor Y. Khandros and Susan Bloch are co-trustees of each such trust.

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.


CUSIP No. 084310101		13G		Page 7 of 9

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not applicable.

Item 8.

Identification and Classification of Members of the Group

Not applicable.

Item 9.

Notice of Dissolution of Group

Not applicable.

Item 10.

Certifications

Not applicable.

Exhibits


Exhibit 99.1		Agreement Regarding Joint Filing of Statements on Schedule 13G

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 16, 2021

Date

/s/ Igor Y. Khandros

Igor Y. Khandros

Individually and as Trustee of the Khandros-Bloch Revocable Trust U/A/D January 24, 1997

February 16, 2021

Date

/s/ Susan Bloch

Susan Bloch

Individually and as Trustee of the Khandros-Bloch Revocable Trust U/A/D January 24, 1997

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations.

(See 18 U.S.C. 1001)

NAMES OF REPORTING PERSONS.

  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

  Igor Y. Khandros

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐ (b) ☐

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

UNITED STATES